Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Epididymal metastases as the first sign of a colon cancer recurrence
Authors
Fernando Moreno Antón
Javier Sastre Valera
Belén Loboff de León
Sara López-Tarruella
Luis Ortega Medina
Eduardo Díaz-Rubio
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 7/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710272

Other articles of this Issue 7/2005

Clinical and Translational Oncology 7/2005 Go to the issue

Original Articles

Hartmann’s procedure for obstructive carcinoma of the left colon and rectum: a comparative study with one-stage surgery

Case Reports

Metastases in the sphenoidal sinus in a patient with papillary thyroid cancer

Review

Sedation in clinical oncology

Editorial

El final de la última enfermedad

Educational Review

Estado actual del diagnóstico y tratamiento del hepatoblastoma

Original Articles

Radioquimioterapia de la enfermedad limitada del carcinoma pulmonar de célula pequeña. ¿Tratamiento concomitante en protocolos asistenciales?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits